Evidence map›Paper›PMID 25261746›Full record

ArticleCytokine2015

Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2.

Michael S Valerio, Bethany A Herbert, Dimitrios S Basilakos, Courtney Browne, Hong Yu, Keith L Kirkwood

Open access · greenAbstract read
In one paragraph

Article in Cytokine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Oral Osteomicrobiology: The Role of Oral Microbiota in Alveolar Bone Homeostasis.Frontiers in cellular and infection microbiology · 2021
    Review
  9. Article
  10. Article
  11. Virulence and Pathogenicity Properties ofPathogens (Basel, Switzerland) · 2019
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael S ValerioDepartment of Oral Health Sciences and the Center for Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA. Electronic address: valeriom@musc.edu.
Bethany A HerbertDepartment of Oral Health Sciences and the Center for Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA. Electronic address: herbertb@musc.edu.
Dimitrios S BasilakosDepartment of Oral Health Sciences and the Center for Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA. Electronic address: basilako@musc.edu.
Courtney BrowneDepartment of Oral Health Sciences and the Center for Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
Hong YuDepartment of Oral Health Sciences and the Center for Oral Health Sciences, Medical University of South Carolina, Charleston, SC, USA. Electronic address: yuho@musc.edu.
Keith L KirkwoodDepartment of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA. Electronic address: klkirk@musc.edu.
Medical University of South Carolina · US

Funding

T-COHR: Training in Craniofacial and Oral Health ResearchT32DE017551 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI YAO, HAI · 2006 to 2025
$10.3M
Pilot and Feasibility Project ProgramP30GM103331 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KIRKWOOD, KEITH L · 2012 to 2016
$5.2M
Post-Transcriptional Regulation of Periodontal DiseR01DE021423 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KIRKWOOD, KEITH L · 2011 to 2015
$2.1M
Negative Regulation of Innate Immune Responses through MAPK PhosphatasesR01DE018290 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIRKWOOD, KEITH L · 2007 to 2011
$1.8M
T-COHR: Summer Undergraduate Research ProgramR25DE022677 · NIDCR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CRAY, JAMES J. · 2012 to 2016
$263k
NIDCR NIH HHS 5R01DE018290NIDCR NIH HHS 5R01DE021423NIDCR NIH HHS R01 DE018290NIDCR NIH HHS R01 DE021423NIDCR NIH HHS R25 DE022677NIDCR NIH HHS R25DE022677NIDCR NIH HHS T32 DE017551NIDCR NIH HHS T32DE017551-05NIGMS NIH HHS P30 GM103331NIGMS NIH HHS P30GM103331
6 · The paper itself

Abstract

unlabelledOsteoclast (OC) progenitors (OCP) have been defined in the bone marrow (BM) as CD3(-)CD45R(B220)(-)GR1(-)CD11b(lo/)(-)CD115(+) (dOCP) and more recently in the peripheral blood (PB) as Lym(-)Ly6G(-)CD11b(+)Ly6C(+). These progenitors respond to stimuli, including LPS from periopathogenic Aggregatibacter actinomycetemcomitans, activating MAPK signaling, resulting in cytokine/chemokine-mediated osteoclastogenesis. Intracellular negative signaling pathways, including MAPK phosphatase-1 (MKP-1, gene Dusp1) deactivate MAPK pathways (p-p38 and p-JNK) and reduce inflammatory cytokines/chemokines.

objectiveTo delineate the role of MKP-1 in chemokine-mediated OC formation using defined OC progenitor populations. Given its role in innate immune inflammatory signaling, we hypothesize that MKP-1 regulates LPS-induced OC formation from BM OCP through deregulated chemokines.

methodsBM and PB from WT and Dusp1(-/-) female mice (8-12weeks) was obtained and sorted into defined progenitor populations. BM sorted dOCP were primed with MCSF and RANKL (48h), blocked with vehicle or chemokine blocking antibodies and stimulated with LPS (48-96h). TRAP assay and OC activity were measured for OC formation and activity following treatments. NanoString Array and qPCR were utilized for gene expression analysis.

resultsDusp1(-/-) dOCPs formed more and larger osteoclasts from CD11b(hi) and dOCP compared to matched WT (P<0.05 each). PB-derived dOCP produced larger and more functional osteoclasts from Dusp1(-/-) mice compared to WT controls. NanoString array data revealed significant deregulation in chemokine expression from Dusp1(-/-) versus WT cells. qPCR validation of target genes revealed that Dusp1 deficient CD11b(+) populations display 1.5-3.5-fold greater expression of CXCL1 and 2-3-fold greater expression of CXCL2 compared to WT in CD11b(hi) and dOCP (P<0.05 each). Antibody blocking studies using anti-CXCL1 and CXCL2 antibodies blunted osteoclastogenesis in Dusp1(-/-) cells.

conclusionMKP-1 negatively regulates chemokine-driven OC formation and subsequent bone resorption in response to LPS stimulation. Collectively, these data provide useful insight into mechanisms potentially leading to the development of therapeutic treatment of periodontal disease.

Indexed as

Aggregatibacter actinomycetemcomitansAnimalsBone ResorptionChemokine CXCL1Chemokine CXCL2ChemokinesDown-RegulationDual Specificity Phosphatase 1FemaleLipopolysaccharidesMiceMice, KnockoutOsteoclastsRANK LigandReal-Time Polymerase Chain ReactionStem CellsChemokine CXCL1Chemokine CXCL2ChemokinesCxcl1 protein, mouseCxcl2 protein, mouseDual Specificity Phosphatase 1Dusp1 protein, mouseLipopolysaccharidesRANK LigandChemokinesLipopolysaccharideMKP-1OsteoclastsPeriodontal diseases

Identifiers

PMID25261746
PMCPMC4254057
OpenAlexW1998930862

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.